Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
62,946.36 -549.16 (-0.86%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
EOM Pharmaceuticals Holdings, Inc. (IMUC)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 02:19PM EDT
| Previous close | 0.1979 |
| Open | 0.1575 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 3000 |
| Day's range | 0.1575 - 0.1979 |
| 52-week range | 0.1100 - 0.4000 |
| Volume | |
| Avg. volume | 3,177 |
| Market cap | 22.416M |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | 0.02 |
| EPS (TTM) | 10.9900 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireEOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a peptide-nucleic acid-based broad spectrum immune regulating agent that acts on both key pro-inflammatory and anti-inflammatory cytokines with potential therapeutic utility in treating a variety of acute and chronic inflammatory conditions.
© 2024 Yahoo. All rights reserved.